All In Biotech

Free tool

Drug Search

Every brand-name drug and biologic application (NDA or BLA) in Drugs@FDA: 5,899 in all. Generic (ANDA) applications are not listed; their reference drug is.

Last checked: Nov 20, 2026Drugs@FDA last updated: Nov 18, 2026Methods & limitations

3 matches for "Ascendis"

Brand names that start with your search come first, then marketed and novel drugs.

DrugSponsorApplicationFirst approvedPrograms
Skytrofa

Lonapegsomatropin-Tcgd

Ascendis Pharma Encocrinology Div A/SBLA761177Aug 25, 2021NovelOrphan
Yuviwel

Navepegritide

AscendisNDA219164Feb 27, 2026NovelAccelerated approvalPriority reviewOrphan
Yorvipath

Palopegteriparatide

Ascendis Pharma BoneNDA216490Aug 9, 2024NovelPriority reviewOrphan

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.